Source: Atherosclerosis (suppl.). Conference titles: International Symposium on Atherosclerosis. Unidades: FCF, FM
Assunto: DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHACRA, A. et al. The removal from plasma of a chylomicron-like emulsions is reduced in subjects with the metabolic syndrome: effects of metformin and rosiglitazone. Atherosclerosis (suppl.). Kyoto: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2003APA
Chacra, A., Santos, R., Silva, V., Vinagre, C., Gagliardi, A., Martinez, T., et al. (2003). The removal from plasma of a chylomicron-like emulsions is reduced in subjects with the metabolic syndrome: effects of metformin and rosiglitazone. Atherosclerosis (suppl.). Kyoto: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Chacra A, Santos R, Silva V, Vinagre C, Gagliardi A, Martinez T, Ramires J, Maranhão RC. The removal from plasma of a chylomicron-like emulsions is reduced in subjects with the metabolic syndrome: effects of metformin and rosiglitazone. Atherosclerosis (suppl.). 2003 ; 4( 2): 49.[citado 2024 set. 29 ]Vancouver
Chacra A, Santos R, Silva V, Vinagre C, Gagliardi A, Martinez T, Ramires J, Maranhão RC. The removal from plasma of a chylomicron-like emulsions is reduced in subjects with the metabolic syndrome: effects of metformin and rosiglitazone. Atherosclerosis (suppl.). 2003 ; 4( 2): 49.[citado 2024 set. 29 ]